INJECTABLE DEPOT FORMULATION COMPRISING CRYSTALS OF ILOPERIDONE

摘要

An injectable depot formulation comprising crystals having Structure (I) wherein R is (FII) and the X5o value of the crystals is from 1 to 200 micron s. Depot formulations containing crystals of iloperidone or its metabolite have the following advantages: (i) release of the crystals in plasma can be correlated with the size of the crystals; (ii) absorption of the crystals in plasma can be correlated with the size of the crystals; (iii) the particle size of the crystals can be controlled by crystal engineering and/or milling ; and (iv) the crystals are stable upon storage, and stable to sterilization procedures, such as gamma irradiation.